• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Desoxycorticosterone pivalate Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759577

Deoxycorticosterone (DOCP) is a mineralocorticoid and is an analog of deoxycorticosterone. Deoxycorticosterone pivalate is used in the treatment,of canine low adrenal cortex hormones. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Desoxycorticosterone pivalate, Inhibitor
Full Product Name
Desoxycorticosterone pivalate
Product Synonym Names
DOCP
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
414.58
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C26H38O4
SMILES
C[C@@]12[C@](CC[C@@H]2C(COC(C(C)(C)C)=O)=O)([H])[C@@]3([H])[C@]([C@@]4(C(CC3)=CC(CC4)=O)C)([H])CC1
CAS Number
808-48-0
Target & IC50
Others
In Vitro
The initial dose of 1.5mg/kg deoxycorticosterone pivalate (DOCP) can effectively control the clinical signs and serum electrolyte concentration of most dogs with Phours. An additional dose reduction is usually required to maintain an injection interval of 28-30 days. Young and growing animals seem to require higher doses.

Product References and Citations for Desoxycorticosterone pivalate, inhibitor

Sieber-Ruckstuhl NS, et al. Evaluation of a low-dose desoxycorticosterone pivalate treatment,protocol for long-term management of dogs with primary hypoadrenocorticism. J Vet Intern Med. 2019 May;33(3):1266-1271.
Sieber-Ruckstuhl NS, et al. Evaluation of a low-dose desoxycorticosterone pivalate treatment,protocol for long-term management of dogs with primary hypoadrenocorticism. J Vet Intern Med. 2019 May;33(3):1266-1271.
Masticatory Muscle Myositis: Pathogenesis, Diagnosis, and treatment,
Masticatory Muscle Myositis: Pathogenesis, Diagnosis, and treatment

Other Notes

Small volumes of Desoxycorticosterone pivalate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Desoxycorticosterone pivalate purchase

MBS5759577 is an inhibitor targeting Desoxycorticosterone pivalate.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000